+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Prostate Cancer Diagnostics Market by Test Type (Confirmatory Tests, Preliminary Tests), Age Group (Age 55-75, Age 75), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337436
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Prostate Cancer Diagnostics Market size was estimated at USD 1.27 billion in 2023, USD 1.45 billion in 2024, and is expected to grow at a CAGR of 14.20% to reach USD 3.23 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Prostate Cancer Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Prostate Cancer Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Prostate Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, bioMérieux SA, Eurolyser Diagnostica, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Koninklijke Philips N.V., mdxhealth BV, Myriad Genetics, Inc., OPKO Health, Inc., Prostatype Genomics AB, Proteomedix AG, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Prostate Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test Type
    • Confirmatory Tests
      • Biopsy
      • PCA3 Tests
      • Trans-Rectal Ultrasound
    • Preliminary Tests
  • Age Group
    • Age 55-75
    • Age< 55
    • Age>75
  • End-User
    • Cancer Research Institutes
    • Hospital Associated Laboratories
    • Independent Diagnostic Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Prostate Cancer Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Prostate Cancer Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Prostate Cancer Diagnostics Market?
  4. What is the market share of the leading vendors in the Prostate Cancer Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Prostate Cancer Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Prostate Cancer Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising aging population and increasing prevalence rate of prostate cancer
5.1.1.2. Growing government’s initiatives for advancement in technology in diagnosis and creating awareness regarding cancer
5.1.2. Restraints
5.1.2.1. Stringent regulations and high cost of diagnosis
5.1.3. Opportunities
5.1.3.1. Innovation in drugs and developments in genomics and proteomics
5.1.3.2. Imaging research and advancements for accurate detection of prostate cancer
5.1.4. Challenges
5.1.4.1. Low success rate of clinical trials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Prostate Cancer Diagnostics Market, by Test Type
6.1. Introduction
6.2. Confirmatory Tests
6.3.1. Biopsy
6.3.2. PCA3 Tests
6.3.3. Trans-Rectal Ultrasound
6.3. Preliminary Tests
7. Prostate Cancer Diagnostics Market, by Age Group
7.1. Introduction
7.2. Age 55-75
7.3. Age < 55
7.4. Age>75
8. Prostate Cancer Diagnostics Market, by End-User
8.1. Introduction
8.2. Cancer Research Institutes
8.3. Hospital Associated Laboratories
8.4. Independent Diagnostic Laboratories
9. Americas Prostate Cancer Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Prostate Cancer Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Prostate Cancer Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AdvaCare Pharma
13.1.2. bioMérieux SA
13.1.3. Eurolyser Diagnostica
13.1.4. Exact Sciences Corporation
13.1.5. F. Hoffmann-La Roche AG
13.1.6. Hologic, Inc.
13.1.7. Koninklijke Philips N.V.
13.1.8. mdxhealth BV
13.1.9. Myriad Genetics, Inc.
13.1.10. OPKO Health, Inc.
13.1.11. Prostatype Genomics AB
13.1.12. Proteomedix AG
13.1.13. Siemens Healthineers AG
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PROSTATE CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PROSTATE CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
FIGURE 8. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
FIGURE 10. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 12. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. PROSTATE CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. PROSTATE CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PROSTATE CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 8. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY PCA3 TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TRANS-RECTAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY PRELIMINARY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 13. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE 55-75, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE < 55, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE>75, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITAL ASSOCIATED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 35. CANADA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. CANADA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 57. CHINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. CHINA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 61. INDIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. INDIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. JAPAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. THAILAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. DENMARK PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. EGYPT PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. FINLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. GERMANY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 130. ITALY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. ITALY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. NORWAY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 146. POLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. POLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 150. QATAR PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. QATAR PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. SPAIN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. TURKEY PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. PROSTATE CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 189. PROSTATE CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 190. PROSTATE CANCER DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • AdvaCare Pharma
  • bioMérieux SA
  • Eurolyser Diagnostica
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • mdxhealth BV
  • Myriad Genetics, Inc.
  • OPKO Health, Inc.
  • Prostatype Genomics AB
  • Proteomedix AG
  • Siemens Healthineers AG

Methodology

Loading
LOADING...

Table Information